WBR0702

Jump to navigation Jump to search


Author [[PageAuthor::Mohamed Moubarak, M.D. [1]]]
Exam Type USMLE Step 3
Main Category Community Medical Health Center, Primary Care Office
Sub Category Infectious Disease
Prompt 30 year old female nurse accidentally pricks her finger with a needle used to draw a blood sample from HIV-positive patient. The patients laboratory testing showed CD4 count of 410/mm3 and HIV load of 12,000copies/mL. HIV test to the nurse turn to be negative, she has no significant medical history and taking no medications. Her immunizations are up to date. What is the best approach to handle this situation?
Answer A Four weeks therapy with one nucleoside reverse transcriptase inhibitor and one protease inhibitor
Answer A Explanation Incorrect

Therapy with one nucleoside reverse transcriptase inhibitor and one protease is not recommended

Answer B Six month therapy with one nucleoside reverse transcriptase inhibitor and one protease inhibitor
Answer B Explanation Incorrect

Therapy with one nucleoside reverse transcriptase inhibitor and one protease is not recommended

Answer C Four weeks therapy with two nucleoside reverse transcriptase inhibitor
Answer C Explanation Correct

Immediate therapy with prophylactic two nucleoside reverse transcriptase inhibitor after exposure and continued for 4 weeks is recommended

Answer D Four month therapy with two nucleoside reverse transcriptase inhibitor
Answer D Explanation Incorrect

Although the use of two nucleoside reverse transcriptase inhibitor is recommended, the duration should be Four weeks rather than Four months

Answer E No antiretroviral therapy unless she is HIV positive
Answer E Explanation Incorrect

No action to HIV exposure is not recommended, systemic infection doesn’t occur immediately after inoculation with HIV. Therefore any health care worker exposed to HIV-positive bodily fluids should use a prophylactic regimen to minimize becoming HIV-positive

Right Answer C
Explanation Exposure to body fluids of HIV-positive patient should be followed within hours by antiretroviral prophylaxis. Regimen include two nucleoside reverse transcriptase inhibitor (zidovudine and lamivudine ) for four weeks, some experts suggest adding protease inhibitor (e.g. indinavir ) if viral resistance to the post exposure prophylaxis is suspected

Educational Objective:
References:

Approved No
Keyword
Linked Question
Order in Linked Questions